Les Ulis, France

Christiane Rayssiguier

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Mixis France S.a.. Active years: 1999.


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 72(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christiane Rayssiguier: Innovator in DNA Recombination

Introduction

Christiane Rayssiguier is a notable inventor based in Les Ulis, France. She has made significant contributions to the field of genetic engineering, particularly in the area of DNA recombination. With a total of 2 patents, her work has the potential to advance our understanding of genetic manipulation.

Latest Patents

Rayssiguier's latest patents focus on a process for the in vivo recombination of DNA sequences that have mismatched bases. The first patent describes a method for recombining partially homologous DNA sequences with up to 30% base mismatches. This innovative process involves placing these sequences together in cells or organisms where the enzymatic mismatch repair system is either defective or temporarily inactivated. This allows for effective recombination between the DNA sequences, utilizing mutants that enhance intergeneric recombination.

Career Highlights

Throughout her career, Christiane Rayssiguier has worked with various organizations, including Mixis France S.A. and her own entity. Her expertise in genetic research has positioned her as a key figure in her field, contributing to advancements in DNA technology.

Collaborations

Rayssiguier has collaborated with notable scientists, including Miroslav Radman. These partnerships have further enriched her research and expanded the impact of her inventions.

Conclusion

Christiane Rayssiguier's work in DNA recombination showcases her innovative spirit and dedication to advancing genetic research. Her contributions are paving the way for future developments in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…